Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Merck KGaA ‘looking for acquisitions’

Merck KGaA ‘looking for acquisitions’

8th July 2008

Merck KGaA is reportedly looking to make acquisitions to its pharmaceuticals or chemicals divisions.

Karl-Ludwig Kley, chief executive officer of the firm, told Handelsblatt that the firm would not sell the chemicals division, describing the segment as part of the company’s DNA, Thomson Financial reports.

He also told the paper that while the firm was “intensively” considering its purchase options, it would not be indiscriminate in a bid to generate news stories.

“We won’t run around panting just to produce headlines,” he told the leading German economy newspaper.

He added that the combination of pharmaceuticals and chemicals at the company is non-negotiable and was not up for discussion.

In October 2007, Merck KGaA completed the sale of its generics business to Mylan for a total sum of 4.9 billion euros (3.4 billion pounds).

The deal was originally signed in May 2007 and included a clause whereby Mylan would be permitted to use the Merck name in relation to this segment for two years.

Merck Generics is a unit with almost 5,000 employees and generated sales of 1.8 billion euros in 2006.

In April 2008, Merck Serono and EMD Serono – both Merck KGaA subsidiaries – anounced plans to expand the presence of EMD Serono with the investment of $50 million (25.3 million pounds) in a research centre.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.